LabGenomics Co., Ltd. (KOSDAQ:084650)

LabGenomics Statistics

Total Valuation

LabGenomics has a market cap or net worth of KRW 185.23 billion. The enterprise value is 161.40 billion.

Market Cap	185.23B
Enterprise Value	161.40B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

LabGenomics has 74.24 million shares outstanding. The number of shares has decreased by -0.39% in one year.

Current Share Class	74.24M
Shares Outstanding	74.24M
Shares Change (YoY)	-0.39%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	6.88%
Float	61.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.11
PB Ratio	0.98
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.61
EV / Sales	1.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.71

Financial Position

The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.26.

Current Ratio	1.87
Quick Ratio	1.77
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-2.04
Interest Coverage	-6.57

Financial Efficiency

Return on equity (ROE) is -16.88% and return on invested capital (ROIC) is -8.64%.

Return on Equity (ROE)	-16.88%
Return on Assets (ROA)	-7.76%
Return on Invested Capital (ROIC)	-8.64%
Return on Capital Employed (ROCE)	-17.29%
Revenue Per Employee	615.18M
Profits Per Employee	-245.04M
Employee Count	143
Asset Turnover	0.31
Inventory Turnover	16.24

Taxes

Income Tax	-8.50B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.99% in the last 52 weeks. The beta is -0.28, so LabGenomics's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-18.99%
50-Day Moving Average	2,337.80
200-Day Moving Average	2,489.20
Relative Strength Index (RSI)	69.48
Average Volume (20 Days)	642,545

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LabGenomics had revenue of KRW 87.97 billion and -35.04 billion in losses. Loss per share was -472.25.

Revenue	87.97B
Gross Profit	30.76B
Operating Income	-35.35B
Pretax Income	-43.54B
Net Income	-35.04B
EBITDA	-24.95B
EBIT	-35.35B
Loss Per Share	-472.25

Balance Sheet

The company has 72.86 billion in cash and 49.03 billion in debt, giving a net cash position of 23.83 billion or 320.97 per share.

Cash & Cash Equivalents	72.86B
Total Debt	49.03B
Net Cash	23.83B
Net Cash Per Share	320.97
Equity (Book Value)	189.40B
Book Value Per Share	2,551.12
Working Capital	52.76B

Cash Flow

In the last 12 months, operating cash flow was -22.27 billion and capital expenditures -1.77 billion, giving a free cash flow of -24.04 billion.

Operating Cash Flow	-22.27B
Capital Expenditures	-1.77B
Free Cash Flow	-24.04B
FCF Per Share	-323.81

Margins

Gross margin is 34.97%, with operating and profit margins of -40.19% and -39.83%.

Gross Margin	34.97%
Operating Margin	-40.19%
Pretax Margin	-49.50%
Profit Margin	-39.83%
EBITDA Margin	-28.37%
EBIT Margin	-40.19%
FCF Margin	n/a

Dividends & Yields

LabGenomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.39%
Shareholder Yield	n/a
Earnings Yield	-18.92%
FCF Yield	-12.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 2.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	2

Scores

LabGenomics has an Altman Z-Score of 2.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.42
Piotroski F-Score	3